Komprevo

Medicinal product

(Invented) name

Komprevo

Active substance (s)

Linagliptinas/Metformino hidrochloridas

Strength

2,5 mg/850 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BD11, Metformin and linagliptin

Marketing authorisation holder

Egis Pharmaceuticals PLC, Vengrija

Date of authorisation

2026-06-05

Date of renewal

Documents

6060-61_pakuotes lapelis_2026-06-05.docx

Komprevo_PubAR_SD+Summ+LT.pdf

6060-6061_Komprevo.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LT/H/0231/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Linagliptinas	2,5 mg
Metformino hidrochloridas	850 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121287	107396	1107396	lizdinė plokštelė	N60		Receptinis	LT/1/26/6060/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-06-05	Registruotas